Skip to main content

Peer Review reports

From: Intracranial efficacy of alectinib in ALK-positive NSCLC patients with CNS metastases—a multicenter retrospective study

Original Submission
27 May 2021 Submitted Original manuscript
5 Jul 2021 Author responded Author comments - Zihua Zou
Resubmission - Version 2
5 Jul 2021 Submitted Manuscript version 2
6 Jul 2021 Reviewed Reviewer Report
11 Jul 2021 Reviewed Reviewer Report
5 Sep 2021 Author responded Author comments - Zihua Zou
Resubmission - Version 3
5 Sep 2021 Submitted Manuscript version 3
12 Sep 2021 Author responded Author comments - Zihua Zou
Resubmission - Version 4
12 Sep 2021 Submitted Manuscript version 4
13 Sep 2021 Reviewed Reviewer Report
15 Sep 2021 Reviewed Reviewer Report
22 Oct 2021 Author responded Author comments - Zihua Zou
Resubmission - Version 5
22 Oct 2021 Submitted Manuscript version 5
30 Oct 2021 Reviewed Reviewer Report
1 Nov 2021 Reviewed Reviewer Report
1 Dec 2021 Author responded Author comments - Zihua Zou
Resubmission - Version 6
1 Dec 2021 Submitted Manuscript version 6
Publishing
6 Dec 2021 Editorially accepted
18 Jan 2022 Article published 10.1186/s12916-021-02207-x

You can find further information about peer review here.

Back to article page